Latest Hematopoietic stem cell transplantation Stories
New Cord Tissue Research, Aggressive Product Development and Lower Prices Make Cord Tissue Banking More Appealing NEW YORK, Feb.
ReportsnReports.com adds Capitalizing on Opportunities in Cord Blood Industry Growth research report to its store. DALLAS, Jan.
AMSTERDAM, January 29, 2014 /PRNewswire/ -- ~ Prof. Dr.
DUBLIN, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pgsn5d/complete_201314) has announced the addition of the "2014
DUBLIN, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wfh3fh/capitalizing_on) has announced the addition of the "Capitalizing
DUBLIN, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8pg6t9/capitalizing_on) has announced the addition of the "Capitalizing
Investigators at Johns Hopkins report they have developed human induced-pluripotent stem cells (iPSCs) capable of repairing damaged retinal vascular tissue in mice.
- BL-8040 previously received Orphan Drug Designation for treatment of Acute Myeloid Leukemia - JERUSALEM, Jan.
Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...
- An armed gangster.